On October 24, 2025, Xbrane Biopharma Registered presented the figures for the quarter ended September 30, 2025.
In terms of EPS, a loss of SEK 2.50 per share was reported. Last year, Xbrane Biopharma Registered had generated SEK -3,750 per share.
In the past quarter, Xbrane Biopharma Registered generated sales of SEK 10.1 million. This corresponds to a discount of 84.85 percent compared to the previous year. SEK 66.8 million were sold here.
Editorial team finanzen.net
Selected leverage products on Xbrane Biopharma Registered
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Xbrane Biopharma Registered
The leverage must be between 2 and 20
Advertising